Kiora Pharmaceuticals
KPRX
KPRX
16 hedge funds and large institutions have $625K invested in Kiora Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
68% less capital invested
Capital invested by funds: $1.93M → $625K (-$1.31M)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$20K | |
| 2 | +$15K | |
| 3 | +$11K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8.8K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6K |
Top Sellers
| 1 | -$77K | |
| 2 | -$72K | |
| 3 | -$34.8K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$27K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$10K |